|
|
|
|
AMRI Announces Fourth Quarter 2009 Results
AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ending December 31, 2009.Financial and other highlights for the fourth quarter and year include: Fourth Quarter 2009 Results Total revenue for the fourth...
|
|
|
AMRI reports $19M net loss in 4Q
A goodwill impairment charge, and lower contract revenue, led to a report net losses for the fourth quarter and all of 2009.For the fourth quarter, the Albany, N.Y.-based drug discovery and manufacturing company had a net loss of $19.2 million, or 62 cents a...
|
|
|
Nice, Novartis, Very Nice
I hope Novartis (NYSE: NVS) Chairman and CEO Daniel Vasella doesn't feel too bad about giving up his CEO spot and seeing shares move up nearly 2% yesterday.I'm pretty sure it had more to do with the 47% increase in fourth-quarter earnings than a statement...
|
|
|
Nice, Novartis, Very Nice
Recs 0 //Create your sharelet with desired properties and set button element to false object //Tie customized button to This button functionality.element Disney Buys Marvel! David Gardner called it! Hes up 1,334%! See what Davids recommending that you...
|
|
|
Nice, Novartis, Very Nice
I hope Novartis (NYSE: NVS) Chairman and CEO Daniel Vasella doesn't feel too bad about giving up his CEO spot and seeing shares move up nearly 2% yesterday.I'm pretty sure it had more to do with the 47% increase in fourth-quarter earnings than a statement...
|
|
|
FTC clears Sanofi-Aventis purchase of Chattem
Sanofi-Aventis says review of $1.9B deal for Gold Bond maker is over, paving the way for sale Companies: Related On Tuesday January 26, 2010, 10:58 am NEW YORK (AP) -- Regulators have cleared Sanofi-Aventis' $1.9 billion purchase of Gold Bond skin products...
|
|
|
The switch
French pharma Sanofi-Aventis SA cited several reasons for its $1.9 billion purchase of Chattem Inc., the Chattanooga, Tenn., maker of Gold Bond, Icy Hot and other over-the-counter health brands, announced in December.By far the most important, though, was...
|
|
|
Did Sanofi's diversity boost profits 20%?
What's the best pharma business?The vaccines business? At least that's the opinion of Sanofi-Aventis CEO Chris Viehbacher. He told the J.P. Morgan Healthcare conference that this "best business" is a key part of his plans to diversify at Sanofi. And...
|
|
|
Sanofi-Aventis CEO on Pharmas Lost Decade
Chris Viehbacher, CEO of Sanofi-Aventis, spoke yesterday at that big drug-industry meeting in San Francisco.He described pharmas lost decade of the past 10 years for many companies, he said, share prices fell despite double-digit earnings growth. The...
|
|
|
Sanofi bags consumer healthcare specialist Chattem
Sanofi-Aventis looks set to become much bigger in over-the-counter pharmaceuticals with a $1.9 billion agreement to buy US company Chattem.If completed, the acquisition will push the French drugmaker up from number six to number five in the global OTC market...
|
|
|
Spurious drugs worth Rs 2.3 lakh seized by drug control officials in Jaipur
A spurious drug racket has been busted in Amagadh area in Jaipur where the state drug control officials have seized 13 products worth Rs 2.3 lakh along with labels, empty bottles and manufacturing machinery used to produce the fake products.In a raid on...
|
|
|
Sanofi-aventis to acquire Chattem for US$ 1.9 billion
Sanofi-aventis and Chattem, Inc have entered into a definitive agreement under which sanofi-aventis is to acquire 100 per cent of the outstanding shares of Chattem in a cash tender offer for US$ 93.50 per share, or approximately US$ 1.9 billion.The...
|
|
|
Sanofi-Aventis to buy Gold Bond maker Chattem for US$1.9bil
TRENTON, New Jersey: French drugmaker Sanofi-Aventis SA said Monday it plans to buy U.S.health-care company Chattem Inc., maker of over-the-counter mainstays like Gold Bond skin products, for $1.9 billion in cash. The deal also gives Sanofi-Aventis a...
|
|
|
Sanofi-Aventis to buy Gold Bond maker Chattem
TRENTON, N.J.(AP) - French drugmaker Sanofi-Aventis SA said Monday it plans to buy U.S. health-care company Chattem Inc., maker of over-the-counter mainstays like Gold Bond skin products, for $1.9 billion in cash. The deal also gives Sanofi-Aventis a...
|
|
|
Sanofi-Aventis to buy Gold Bond maker Chattem
file photo, Sanofi CEO, Chris Viehbacher, delivers his speech during the launch of Sanofi Pasteur's new plant, Sanofi's 11th vaccine production plant in the world.French drugmaker Sanofi-Aventis SA said Monday, Dec. 21, 2009, it plans to buy U.S. health...
|
